Home › NDC Lookup › Ingredients › Castor Oil › 70000-0024-01
💊image loading
(from DailyMed)

Leader Castor Oil 1 g/mL Oil, 118 mL — NDC 70000-0024-1 (Billing 70000-0024-01)

by Cardinal Health, 110 dba Leader · 118 mL in 1 BOTTLE, PLASTIC

This is a package of 118 mL of Leader Castor Oil 1 g/mL Oil from Cardinal Health, 110 dba Leader, marketed since Mar 2019 and currently FDA-listed; retail pharmacies pay about $0.0188 per mL (NADAC). It is this product's only package size.

NDC 70000-0024-01
🏷️ FDA NDC (as labeled) 70000-0024-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70000-0024-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70000 labeler · 0024 product · 1 package
Package marketed since
Mar 12, 2019
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
118 mL per package
Barcode (UPC-A, from the NDC)
3 7000000241 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0024-1
Product NDC 70000-0024
11-digit billing NDC 70000002401
NCPDP billing unit ML — per mL (volume)
RxCUI 204691
UNII D5340Y2I9G
Application # M007
SPL Set ID 49e3a40a-b717-43f6-abed-473d7ed03c2e
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-03-12
Route ORAL
Dosage form OIL
Substance CASTOR OIL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200030001799
GPI class Castor Oil
GCN Seq No 062768
GCN 98542
HICL code 001313
Ingredient (HICL) Castor Oil
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name CASTOR OIL
FDB brand name Castor Oil
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 062768
  • GCN: 98542
  • GPI-14 (Medi-Span): 46200030001799
  • HICL (First Databank): 001313
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 204691
Why two NDCs? The FDA registers this code as 70000-0024-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0024-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CASTOR OIL Ingredient Castor Oil
📗 Our plain-language guide HelloPharmacist
  • Most people can expect a bowel movement within 6 to 12 hours of taking a dose. So if you take it in the morning, you'll likely see results before the end of the day. Because it wor...
  • How quickly will castor oil work for constipation?
  • The labels for most oral castor oil products recommend taking it on an empty stomach for best results. If the taste is a problem — and it can be — try mixing it with juice. That's...
  • Should I take it with food or on an empty stomach?
📖 Read our full Castor Oil guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.019 $2.22 / 118 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2023 Jan 2026 May 2026 Sep 2026 $0.019 $0.018
▼ Down 2% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0024-01 You're viewing this Main listing 118 mL in 1 BOTTLE, PLASTIC 2019-03-12 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Leader Castor Oil 1 g/mLthis 70000-0024-01 Cardinal 118 ml $0.019 — Availability likely —
GNP Castor Oil 1 mg/mL 24385-0515-30 Amerisource 177 ml $0.020 — Availability likely +6%
Foster and Thrive Castor Oil 1 mg/mL 70677-1085-01 Strategic 177 ml $0.020 — Availability likely +6%
Castor Oil 1 mg/mL 70677-1317-01 STRATEGIC 177 ml $0.020 — Availability likely +6%
Quality Choice Castor Oil 1 mg/mL 63868-0322-06 Chain 177 ml $0.021 — FDA listed +10%
Well at Walgreens Castor Oil 1 g/mL 00363-0078-26 Walgreen 118 ml — — FDA listed —
Humco Castor Oil (Regular) 1 mg/mL 00395-0513-94 Humco 118 ml — — FDA listed —
Humco Castor Oil 1 mg/mL 00395-0515-16 Humco 473 ml — — FDA listed —
Castor Oil 1 g/mL 00869-0078-26 Vi-Jon, 118 ml — — FDA listed —
Castor Oil 1 g/mL 11344-0078-26 Nice-Pak 118 ml — — FDA listed —
Signature Care 1 g/mL 21130-0078-26 Better 118 ml — — FDA listed —
De La Cruz Castor Oil 1 g/mL 24286-1526-05 DLC 59 ml — — FDA listed —
Castor Oil 1 g/mL 36800-0952-26 Topco 118 ml — — FDA listed —
Castor Oil 1 mg/mL 41163-0078-26 United 118 ml — — FDA listed —
Castor Oil 1 g/mL 72476-0017-26 Retail 118 ml — — FDA listed —
Castor Oil 1000 mg/mL 75981-0078-26 Perrigo 118 ml — — FDA listed —
Castor Oil 1000 mg/mL 79481-0782-06 Meijer, 118 ml — — FDA listed —
Castor Oil 1 g/mL 83324-0055-04 Chain 118 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Mar 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Castor Oil inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

From the label’s inactive-ingredient sectionnone

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCardinal Health, 110 dba Leader
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedMar 2019
Product typeHuman Otc Drug
Portfolio34 products on file

More NDCs from Cardinal Health, 110 dba Leader labeler code 70000

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🤒 Adverse Reactions 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

Use For relief of occasional constipation (irregularity). Generally produces bowel movement in 6 to 12 hours.

⏱️ Dosage and Administration 61 words ▾

Directions Adults and children over 12 years of age: 1 to a maximum of 4 tablespoons (15 to 60 mL) in a single daily dose Children 2 to under 12 years of age: 1 to a maximum of 3 teaspoons (5 to 15 mL) in a single daily dose Children under 2 years of age: do not use, consult a doctor

⚠️ Warnings 4 words ▾

Warnings for this product

🤒 Adverse Reactions 15 words ▾

Adverse reactions Dist. by CAH, Dublin, OH 43017 ©2025 Cardinal Health CIN 5516034 REV. 09/25

🧪 Active Ingredient 6 words ▾

Active ingredient Castor oil USP 100%

🧪 Inactive Ingredients 3 words ▾

INACTIVE INGREDIENT none

🎯 Purpose 3 words ▾

Purpose Stimulant Laxative

📄 Do Not Use 10 words ▾

Do not use for a period longer than 1 week

📄 Ask a Doctor Before Use If 28 words ▾

Ask a doctor before use if you have abdominal pain, nausea, or vomiting noticed a sudden change in bowel habits that persists over a period of 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 33 words ▾

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work.

📄 Stop Use and Ask a Doctor If 28 words ▾

Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use. These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Other Information 9 words ▾

Other information Keep tightly closed, away from excessive heat.

📄 Questions or Comments 2 words ▾

Questions? 1-888-593-0593

📄 Package Label / Principal Display Panel 42 words ▾

principal display panel LEADER ™ NDC 70000-0024-1 Castor Oil USP Stimulant Laxative 100% Money Back Guarantee For the Relief of Occasional Constipation 4 FL OZ (118 mL) DO NOT USE IF SEAL UNDER CAP IS BROKEN OR MISSING. image description image description

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Leader Castor Oil (this brand).

Top reported reactions

Fatigue23
Diarrhoea22
Nausea20
Constipation16
Fall16
Asthenia14
Headache14

Age at onset

Neonate1
Adult27
Elderly16

Reporter sex

184 reports
Male · 33%
Female · 67%

Serious outcomes

Hospitalization59
Life-threatening8
Disabling6
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 18 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70000-0023-01 · Cardinal 70000-0026-01 · Cardinal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.